Compounded Semaglutide and Tirzepatide in Illinois: How to Access GLP-1 Treatment Online

Quick answer: Illinois residents can access compounded semaglutide and compounded tirzepatide through telehealth, with no in-person visit required. Fig serves all 50 states, including Illinois. You complete a free online health assessment, a U.S.-licensed provider reviews your medical history, and medication is prescribed only if it is clinically appropriate for you. Fig's plans start at $145/month* for compounded semaglutide and $258/month* for compounded tirzepatide, with no membership fee and free shipping. Compounded medications are not FDA-approved.

Illinois is home to nearly 13 million people, and weight management is a meaningful public health challenge across the state. According to the Trust for America's Health State of Obesity 2025 report, which analyzes 2024 BRFSS data, 29.3% of Illinois adults have obesity.1 That represents millions of Illinois residents who may benefit from evidence-based treatment.

Illinois expanded Medicaid under the Affordable Care Act, and the state's uninsured rate is relatively low: according to the U.S. Census Bureau's 2024 American Community Survey, 6.2% of Illinois residents are uninsured — below the national average of 7.9%.2 However, Medicaid and most private insurance plans in Illinois do not cover compounded GLP-1 medications, and even brand-name coverage requires extensive prior authorization. For Illinois residents in Chicago, Springfield, Rockford, La Grange, and communities across the state, online telehealth programs like Fig offer a transparent, affordable path to GLP-1 treatment.

Start Your Free Assessment →

Can I Get Compounded GLP-1 Medication in Illinois?

Yes. Fig is a telehealth platform that serves all 50 states, including Illinois. The process is entirely online — no in-person visit, no waiting room, and no travel required.

You complete a free online health assessment, a licensed medical provider reviews your information, and if treatment is determined to be clinically appropriate, a prescription is issued and medication is shipped directly to your Illinois address at no additional shipping cost.

What Does Fig Offer Illinois Residents?

Fig offers access to compounded semaglutide and compounded tirzepatide when prescribed by a licensed provider as clinically appropriate. Both medications are prepared by state-licensed, FDA-registered 503A compounding pharmacies in the United States.

Fig's pricing is all-inclusive with zero membership fees, zero consultation fees, and zero shipping charges added at checkout.

Medication Monthly Plan 3-Month Plan 6-Month Plan Compounded Semaglutide $175/mo $165/mo $145/mo Compounded Tirzepatide $279/mo $265/mo $258/mo

Many competing telehealth platforms charge a mandatory monthly membership fee of $100 to $149 on top of medication costs. Fig charges zero membership fees. The price shown is the total price paid.

How the Fig Process Works in Illinois

1. Complete Fig's free online health assessment from anywhere in Illinois, covering your medical history, current medications, and weight management goals.

2. A licensed medical provider reviews your information and determines whether treatment is clinically appropriate.

3. If a prescription is issued, pricing is shown transparently before any payment is required.

4. Medication and supplies are shipped discreetly to your Illinois address at no additional shipping cost.

5. Ongoing support is included throughout your treatment experience.

The process is fully asynchronous. There are no scheduled video appointments, and you can complete the intake on your own schedule, whether you are in the Chicago metro area or downstate Illinois.

Does Insurance Cover GLP-1 Medication in Illinois?

Most insurance plans in Illinois, including Illinois Medicaid (Medicaid Managed Care), do not cover compounded GLP-1 medications. Coverage for brand-name GLP-1s like Ozempic and Wegovy exists in some commercial plans but typically requires prior authorization, a documented diagnosis of obesity or type 2 diabetes, and often documented failure of prior weight loss interventions.

Fig does not require insurance to begin. The eligibility process is open to any Illinois resident who meets the clinical criteria.

FSA and HSA funds may be eligible for use toward Fig's plans. Compounded GLP-1 medications prescribed for a diagnosed medical condition generally qualify as a medical expense under IRS guidelines. Check with your plan administrator to confirm.

Frequently Asked Questions

Does Fig ship to all parts of Illinois, including rural areas?

Yes. Fig ships to all Illinois addresses, including Chicago, the suburbs, Springfield, Rockford, Peoria, and rural communities throughout the state.

Do I need an Illinois-licensed doctor to use Fig?

No. Fig's network of licensed providers can evaluate and prescribe for Illinois residents through the telehealth platform.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide is not the same as, nor a substitute for, FDA-approved semaglutide products such as Ozempic or Wegovy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.

Can I use my FSA or HSA card to pay for Fig?

In most cases, yes. Because Fig's pricing is all-inclusive with no separate membership fee, the full cost is typically eligible as a qualified medical expense. Confirm with your FSA or HSA administrator.

Can I cancel anytime?

Yes. Fig offers month-to-month options and patients can cancel anytime, subject to any active orders already in processing.

Getting Started

Illinois residents looking for transparent, affordable access to GLP-1 weight management can start Fig's free eligibility assessment at startfig.com.

Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Fig does not guarantee weight loss results. Individual outcomes vary. Treatment is only prescribed when a licensed provider determines it is clinically appropriate.

Footnotes

1. Trust for America's Health. State of Obesity 2025: Better Policies for a Healthier America. 2024 BRFSS data. https://www.tfah.org/report-details/state-of-obesity-report-2025/ ↩

2. U.S. Census Bureau. Health Insurance Coverage by State: 2023 and 2024. American Community Survey 1-Year Estimates, 2024. https://www2.census.gov/library/publications/2025/demo/acsbr-024.pdf ↩

Keep reading

Comparing providers? Browse the full GLP-1 provider comparison library, or see all guides in the Fig Journal.

Related: How Much Does Semaglutide Cost Without Insurance in 2026?

Also helpful: What Are GLP-1s? The Science Behind Modern Weight Management

Wondering whether GLP-1 treatment could be right for you? Take the free assessment to see if you qualify.

Important Safety Information: Common side effects of compounded semaglutide and compounded tirzepatide may include nausea, vomiting, diarrhea, stomach pain, and constipation. Serious side effects may include inflammation of the pancreas (pancreatitis), gallbladder problems, increased risk of low blood sugar (hypoglycemia), kidney problems, and serious allergic reactions. These medications should not be used if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Telehealth Disclosure: Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. A prescription is not guaranteed. Rx required. Not available in all states. The information provided on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Compounding Disclosure: Compounded products are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded semaglutide and compounded tirzepatide are not the same as, nor substitutes for, FDA-approved semaglutide products (Wegovy®, Ozempic®) or tirzepatide products (Mounjaro®, Zepbound®). Compounded medications are not generic drugs. Fig is partnered with state-licensed, FDA-registered 503A compounding pharmacies that prepare all medications.